KBI Biopharma, Inc., a JSR Life Sciences company, appointed Marykay Marchigiani chief financial officer and Sigma Mostafa, chief scientific officer. In a statement, the company said that the additions will allow KBI to fulfill its growth strategy of becoming a next-generation CDMO. Marchigiani is a certified public accountant who joins KBI with over two decades of executive financial and strategic leadership. She has driven results in numerous functional areas and industries, including b...